15,000 stroke patients enrolled in shanghai to uncover hidden risk factors
NCT ID NCT07171242
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study will follow 15,000 people in Shanghai who have had an ischemic stroke. Researchers will collect detailed information on risk factors, treatments, and recovery to better understand why strokes happen, especially in younger adults. The goal is to improve stroke prevention and care in the region.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- What this could lead to
- If successful, this could reveal new risk factors and trends for stroke in young people, helping shape better prevention strategies.
- What could go wrong
- This is an observational registry, not a treatment trial. It cannot prove cause and effect, and results may not apply outside Shanghai.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 15,000 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Dec 2024
- Expected to finish
-
Dec 2029
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Patients aged 18 years or older diagnosed with acute or subacute ischemic stroke
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: 1. Patients aged 18 years or older diagnosed with acute or subacute ischemic stroke 2. The diagnosis of stroke must be confirmed through clinical assessment and imaging examinations 3. In cases where imaging examinations are negative or unavailable, the clinical diagnosis of stroke must be confirmed by an experienced neurologist. (4)Patients must sign an informed consent form agreeing to the collection of information. Exclusion Criteria: 1. The amount of missing data exceeds 40% of the data to be entered; 2. After enrollment, it is discovered that the study participant does not meet the inclusion criteria or meets any of the exclusion criteria; 3. Missing persons
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Ischemic stroke are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Huashan hospital Fudan University
RECRUITINGShanghai, Shanghai Municipality, 200040, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a checklist and heart monitor stop repeat strokes?
- Heart hole or stroke trigger? global registry tracks who gets closure and what happens next
- Two ways to catch a hidden heart rhythm after stroke
- Blood test may reveal who recovers after a stroke
- Can a smart bracelet and app stop a second stroke?
- Pharmacist and coach team takes aim at blood pressure after stroke